Evidence map›Paper›PMID 33527189›Full record

ReviewJournal of general internal medicine2021

Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors.

Donna Langenbahn, Yuka Matsuzawa, Yuen Shan Christine Lee, Felicia Fraser, Donald B Penzien, Naomi M Simon, Richard B Lipton, Mia T Minen

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of general internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Psychological interventions for migraine.Nature reviews. Neurology · 2026
    Review
  4. Article
  5. Article
  6. Addressing the overuse-underuse paradox in healthcare.Medicine, health care, and philosophy · 2025
    Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Non-Pharmacological Treatment for Chronic Migraine.Current pain and headache reports · 2023
    Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Donna LangenbahnDepartment of Rehabilitation Medicine, NYU Langone Health, New York, NY, USA.
Yuka MatsuzawaDepartment of Rehabilitation Medicine, NYU Langone Health, New York, NY, USA.
Yuen Shan Christine LeeDepartment of Rehabilitation Medicine, NYU Langone Health, New York, NY, USA.
Felicia FraserDepartment of Physical Medicine & Rehabilitation, MetroHealth System, Cleveland, OH, USA.
Donald B PenzienDepartments of Psychiatry and Behavioral Medicine, Neurology, Wake Forest University College of Medicine, Winston-Salem, NC, USA.
Naomi M SimonDepartment of Psychiatry, NYU Langone Health, New York, NY, USA.
Richard B LiptonDepartment of Neurology, Albert Einstein College of Medicine, New York, NY, USA.
Mia T MinenDepartment of Neurology, NYU Langone Health, New York, NY, USA. MinenMD@gmail.com.
NYU Langone Health · USAlbert Einstein College of Medicine · USMetroHealth · USWake Forest University · US

Funding

Progressive Muscle Relaxation for Chronic Pain in an Acute Care SettingK23AT009706 · NCCIH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MINEN, MIA · 2018 to 2022
$923k
Doris Duke Charitable Foundation Fund to Retain Clinical ScientistsNCCIH NIH HHS K23 AT009706NCCIH NIH HHS K23 AT009706-01
6 · The paper itself

Abstract

Migraine affects over 40 million Americans and is the world's second most disabling condition. As the majority of medical care for migraine occurs in primary care settings, not in neurology nor headache subspecialty practices, healthcare system interventions should focus on primary care. Though there is grade A evidence for behavioral treatment (e.g., biofeedback, cognitive behavioral therapy (CBT), and relaxation techniques) for migraine, these treatments are underutilized. Behavioral treatments may be a valuable alternative to opioids, which remain widely used for migraine, despite the US opioid epidemic and guidelines that recommend against them. Identifying and removing barriers to the use of headache behavioral therapy could help reduce the disability as well as the personal and social costs of migraine. These techniques will have their greatest impact if offered in primary care settings to the lower socioeconomic status groups at greatest risk for migraine. We review the societal and cultural challenges that impose barriers to optimal use of non-pharmacological treatment services. These barriers include insufficient knowledge of migraine/headache behavioral treatments and insufficient availability of clinicians trained in non-pharmacological treatment delivery; limited access in underserved communities; financial burden; and stigma associated with both headache and mental health diagnoses and treatment. For each barrier, we discuss potential approaches to minimizing its effect and thus enhancing non-pharmacological treatment utilization.Case ExampleA 25-year-old graduate student with a prior history of headaches in college is attending school in the evenings while working a full-time job. Now, his headaches have significant nausea and photophobia. They are twice weekly and are disabling enough that he is unable to complete homework assignments. He does not understand why the headaches occur on Saturdays when he pushes through all week to get through his examinations that take place on Friday evenings. He tried two different migraine preventive medications, but neither led to the 50% reduction in headache days his doctor had hoped for. His doctor had suggested cognitive behavioral therapy (CBT) before initiating the medications, but he had been too busy to attend the appointments, and the challenges in finding an in-network provider proved difficult. Now with the worsening headaches, he opted for the CBT and by the fifth week had already noted improvements in his headache frequency and intensity.

Indexed as

Cognitive Behavioral TherapyMigraine DisordersAdultBehavior TherapyHeadacheHumansNauseabarriers to carebehavioral interventionsheadachemigraine

Identifiers

PMID33527189
PMCPMC7849617
OpenAlexW3126659336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.